Response to Comments: Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)

This response-to-comments document records administrative details (comment period, notice period, effective date) and a title change for LCD L38737 but does not itself define coverage, limitations, documentation, or frequency criteria. For actionable coverage criteria for percutaneous vertebral augmentation for vertebral compression fracture, consult LCD L38737 effective 2022-08-21.

"This response document does not specify clinical indications; refer to LCD L38737 'Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)' (effective 2022-08-21) for cov..."

Sign up to see full coverage criteria, indications, and limitations.